Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein R1, R2, R3 and n have the significance given in claim 1.
申请公布号
US8389539(B2)
申请公布日期
2013.03.05
申请号
US20100951095
申请日期
2010.11.22
申请人
ACKERMANN JEAN;CONTE AURELIA;HUNZIKER DANIEL;NEIDHART WERNER;NETTEKOVEN MATTHIAS;SCHULZ-GASCH TANJA;WERTHEIMER STANLEY;HOFFMAN-LA ROCHE INC.
发明人
ACKERMANN JEAN;CONTE AURELIA;HUNZIKER DANIEL;NEIDHART WERNER;NETTEKOVEN MATTHIAS;SCHULZ-GASCH TANJA;WERTHEIMER STANLEY
